In the present study, we found that depletion of KDM4A by either shRNA or its inhibitor SD49-7 could sufficiently impede leukemogenesis, indicating that KDM4A may be a more suitable target in impairing leukemia cells. This evidence concerns the gene KDM4A and leukemia.